Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Collin Okeefe

Orthopaedic Surgery West Bloomfield, MI Doctor of Osteopathy

NPI 1053543090 CMS profile 649738

2300 Haggerty Rd, Suite 1110, West Bloomfield, MI 48323

Open in the dashboard

General payments

$6,062

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Collin Okeefe of West Bloomfield, MI is reported in the CMS Open Payments database as having received $6,062 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $173 6
2024 General $363 9
2023 General $219 8
2022 General $1,384 11
2021 General $1,693 29
2020 General $1,838 25
2019 General $393 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Collin Okeefe
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Collin Okeefe were reported at $173. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Collin Okeefe Orthopaedic Surgery median Middle half National median
2019 $393 $644 $140–$2,844 $163
2020 $1,838 $312 $75–$1,860 $114
2021 $1,693 $520 $117–$2,495 $132
2022 $1,384 $598 $128–$2,731 $149
2023 $219 $461 $128–$2,264 $160
2024 $363 $497 $134–$2,475 $164
2025 $173 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pinnacle, Inc $4,115 8 payments
  2. Stryker Corporation $316 6 payments
  3. Horizon Therapeutics plc $303 38 payments
  4. DePuy Synthes Sales Inc. $220 5 payments
  5. Smith+Nephew, Inc. $195 8 payments
  6. Bioventus LLC $137 6 payments
  7. Globus Medical, Inc. $101 2 payments
  8. Flexion Therapeutics, Inc. $95 4 payments
  9. Fidia Pharma USA Inc. $89 4 payments
  10. Stimwave Technologies Incorporated $57 1 payment
  11. Other $433 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $4,026 4 payments
  2. Food and Beverage $2,008 98 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28 1 payment
Products named General payments · program years 2019–2025
  1. DUEXIS $148 22 payments
  2. PENNSAID $134 13 payments
  3. ALPHAVENT $128 2 payments
  4. INSIGNIA $127 1 payment
  5. LCP $124 1 payment
  6. Distal Femur Plate System $101 2 payments
  7. Zilretta $95 4 payments
  8. HYMOVIS $89 4 payments
  9. DHS $60 1 payment
  10. ZURZUVAE $50 2 payments
  11. Other $1,045 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

189

Median for Orthopedic Surgery: 203

Drug cost

$1,167

Median for Orthopedic Surgery: $1,433

Branded share of claims

39.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 75 $872
Methylprednisolone Generic 27 $131
Ibuprofen Generic 11 $62
Tramadol Hcl Generic 29 $53
Amoxicillin Generic 47 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$97,739

Of which drugs: $4,284

Medicare patients

240

Average age 74

Services billed

2,626

152 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 26%
Ischemic heart disease 26%
Depression 20%
Chronic kidney disease 18%
Cancer 17%
Heart failure 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg J7329 Office 12 500 $2,832
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 110 768 $558

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record